Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Christopher Phillips
Introduction
Christopher Phillips is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Latest Patents
Christopher Phillips holds a patent for "Fused tricyclic compounds useful as anticancer agents." This patent relates to compounds of Formula (A) and pharmaceutically acceptable salts thereof. The specification also details processes and intermediates used for their preparation, as well as pharmaceutical compositions containing these compounds and their application in treating cell proliferative disorders. He has 1 patent to his name.
Career Highlights
Phillips is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects aimed at creating innovative therapies for various diseases.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues, including Jason Grant Kettle and Iain Simpson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christopher Phillips exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of anticancer agents, highlight the importance of research and collaboration in advancing medical science.